O’Melveny Worldwide

China Business Law Journal: Luzhu Biotechnology Launches HKD341m IPO via Chapter 18A

May 10, 2023


O’Melveny represented Beijing Luzhu Biotechnology Co., Ltd. in its initial public offering and listing of H shares on the Main Board of the Hong Kong Stock Exchange. The IPO offering size was approximately HK$340 million (approximately US$43 million) and is the first Hong Kong IPO of a 18A biotech company in 2023. An O'Melveny team led by Ke Zhu and Ke Geng advised Luzhu Biotech on both US and Hong Kong laws.

Read the full article here.

Related Industries
Related Regions